Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

類似資料

• Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
  著者:: Zoli Wainer, 等
  出版事項: (2008-10-01)
• Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
  著者:: Maltoni Roberta, 等
  出版事項: (2006-03-01)
• Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
  著者:: Passardi, Alessandro, 等
  出版事項: (2006)
• Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer
  著者:: Zoli, W, 等
  出版事項: (1999)
• Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer
  著者:: Rocca, Andrea, 等
  出版事項: (2021)